Jump to content

Rosalind A. Segal

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Magioladitis (talk | contribs) at 06:29, 24 September 2016 (use PMID template). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Rosalind Anne Segal is an American neurobiologist. She is a Professor of Neurobiology at Harvard Medical School and the Co-Chair of the Cancer Biology Department at the Dana Farber Cancer Institute.[1] Segal’s work employs modern methods of cell and molecular biology to study the development of the mammalian brain with the goal of understanding how disruption of this normal process leads to the formation of brain malignancies.

Rosalind A. Segal
Rosalind-segal-large
Born1958
New York City, New York
NationalityUnited States
Alma materHarvard University
Known forDevelopmental and Cellular Neuroscience
Scientific career
FieldsNeurobiology
Doctoral advisorDavid. J.L. Luck
Doctoral studentsFiona Watson, Joshua Rubin

Biography

Segal graduated with a joint A.B. degree from Harvard College and Radcliffe College in 1979, and an MD and a PhD from Weill Cornell Medicine and Rockefeller University respectively in 1986. Her dissertation research was conducted in the laboratory of Dr. David Luck. After completing residency training in Neurology in the Harvard affiliated hospitals in the Longwood Medical Area, Segal conducted postdoctoral research molecular neuroscience in the laboratories of Drs. Ronald McKay and Charles Stiles. She started her own laboratory at Harvard Medical School and the affiliated Beth Israel Deaconess Medical Center in 1994 and moved the laboratory to its current site at the Dana Farber Cancer Institute in 1998.

Research

Segal’s research focuses on critical extracellular factors that control the development of the nervous system, from neural stem cells to functional neural circuits. A major focus has been the Sonic Hedgehog (Shh) signaling pathway. Segal defined the motif within Hedgehog proteins critical for binding to proteoglycans, defined the nature of the proteoglycan that serves as a selective Shh receptor, and demonstrated that proteoglycan interactions are needed for a proliferative response to Shh. Mutations that activate Shh signaling cause brain tumors and other malignancies, and thus these studies have provided new approaches for developing therapeutics for treating brain tumors.

Her research has also investigated later stages of brain development when precursor cells migrate away from the stem cell niche where they are born, proliferate, and eventually exit the cell cycle and take on the properties of neurons. Segal and her colleagues identified a factor brain-derived neurotrophic factor (BDNF) as a chemotactic factor that controls neuron migration. Once neurons have migrated to their final destination and become incorporated into functional neural circuits, she has shown that BDNF, and its close relative nerve growth factor (NGF), work together to maintain circuit function. Segal has demonstrated that BDNF and NGF are transported from the outside of a cell to the cell’s interior via signaling endosomes that function as critical mediators of cell survival within mature neural circuits. Segal has also revealed a role for the local translation of select mRNAs at synapses to promote neural circuit survival and function.

Academic Leadership and Awards

In addition to her research, a major emphasis of Segal’s professional life has been devoted toward the education of the next generation of neuroscientists. She has served as a faculty advisor in science at Radcliffe College. She is also the co-chair of the Department of Cancer Biology at Dana Farber Cancer Institute, as well as the Director of Harvard's PhD Program in Neuroscience. She has mentored numerous graduate students and post-doctoral fellows, and serves as a faculty advisor for the Harvard Women in Neuroscience program.

She is the recipient of a number of awards that recognize her teaching and research accomplishments including the Robert Ebert Clinical Scholar’s Award from the Klingenstein Foundation, a McDonnell Foundation Award from the James S. McDonnell Foundation,[2] the National Institutes of Health Director's Pioneer Award in 2006,[3] and the Casty Family Award for Achievement in Mentoring. She was awarded a two-year $250,000 grant from Alex's Lemonade Stand Foundation in 2014.[4]

Selected works

  • Segal, Rosalind A; Takahashi, Hiroshi; McKay, Ronald D.G. Changes in neurotrophin responsiveness during the development of cerebellar granule neurons. Neuron, 1 December 1992. Volume 9, Issue 6, pages 1041–1052, PMID 1463606 doi:http://www.cell.com/neuron/pdf/0896-6273(92)90064-K.pdf
  • Chan, Jennifer A.; Balasubramanian, Srividya; Witt, Rochelle M.; Nazemi, Kellie J.; Choi, Yoojin; Pazyra-Murphy, Maria F.; Walsh, Carolyn O.; Thompson, Margaret & Segal, Rosalind A. Proteoglycan interactions with Sonic Hedgehog specify mitogenic responses. Nature Neuroscience, 15 March 2009. Volume 12, Issue 4, pages 409–17, PMID 19287388. doi 10.1038/nn.2287. http://www.nature.com/neuro/journal/v12/n4/abs/nn.2287.html
  • Filbin, Mariella Gruber.; Dabral, Sukriti K.; Pazyra-Murphy, Maria F.; Ramkissoon, Shakti; Kung, Andrew L.; Pak, Ekaterina; Chung, Jarom; Theisen, Matthew A.; Sun, Yamping; Franchetti, Yoko; Sun, Yu; Shulman, David S.; Redjal, Navid; Tabak, Barbara; Beroukhim, Rameen; Wang, Qi; Zhao, Jean; Dorsch, Marion; Buonamici, Silvia; Ligon, Keith L.; Kelleher, Joseph F.; & Segal, Rosalind A. Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities. Nature Medicine, 23 March 2013. Volume 19, Number 11, pages 1518–1523, PMID 24076665. doi:10.1038/nm.3328. http://www.nature.com/nm/journal/v19/n11/abs/nm.3328.html
  • Dudek, Henryk, Sandeep Robert Datta, Thomas F. Franke, Morris J. Birnbaum, Ryoji Yao, Geoffrey M. Cooper, Rosalind A. Segal, David R. Kaplan, and Michael E. Greenberg. "Regulation of neuronal survival by the serine-threonine protein kinase Akt." Science 275, no. 5300 (1997): 661-665.
  • Ma, Qing, Dan Jones, Paul R. Borghesani, Rosalind A. Segal, Takashi Nagasawa, Tadamitsu Kishimoto, Roderick T. Bronson, and Timothy A. Springer. "Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4-and SDF-1-deficient mice." Proceedings of the National Academy of Sciences 95, no. 16 (1998): 9448-9453.
  • Segal, Rosalind A., and Michael E. Greenberg. "Intracellular signaling pathways activated by neuropathic factors." Annual review of neuroscience 19.1 (1996): 463-489.

References

  1. ^ "Dr. Rosalind Segal appointed as the new Director of the Program in Neuroscience at Harvard Medical School  : Dana Farber PLGA". danafarberplga.org. Retrieved 6 July 2016.
  2. ^ https://www.jsmf.org/grants/2000003/
  3. ^ http://commonfund.nih.gov/pioneer/Recipients06
  4. ^ http://www.dana-farber.org/About-Us/Awards-and-Honors.aspx


Retrieved from "https://en.wikipedia.org/w/index.php?title=Rosalind_A._Segal&oldid=740927456"